Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.
暂无分享,去创建一个
Leaf Huang | Leaf Huang | Lei Miao | Lei Miao | C Michael Lin | C. M. Lin
[1] Wilson Mok,et al. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. , 2006, Cancer research.
[2] R Blumenthal,et al. Design of liposomes for enhanced local release of drugs by hyperthermia. , 1978, Science.
[3] Judith Campisi,et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B , 2012, Nature Medicine.
[4] R K Jain,et al. Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. , 1999, Biophysical journal.
[5] Li Juan Zhang,et al. Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery. , 2012, Biomaterials.
[6] M. Repka,et al. Self-assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin delivery. , 2009, Molecular pharmaceutics.
[7] Z. Cui,et al. Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. , 2013, Molecular pharmaceutics.
[8] G. Wahl,et al. Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy , 2014, Cell.
[9] Ick Chan Kwon,et al. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[10] F. Marincola,et al. Cytokines and Immune Response in the Tumor Microenvironment , 2001, Journal of immunotherapy.
[11] Jing-Ling Zhu,et al. Cellular internalization and in vivo tracking of thermosensitive luminescent micelles based on luminescent lanthanide chelate. , 2008, ACS nano.
[12] R. Deberardinis,et al. A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals , 2013 .
[13] E. Miele,et al. Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer , 2009, International journal of nanomedicine.
[14] Kazunori Kataoka,et al. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling , 2007, Proceedings of the National Academy of Sciences.
[15] T. Bui,et al. Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo. , 2012, ACS nano.
[16] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[17] A. Mammoto,et al. Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. , 2013, The American journal of pathology.
[18] Bengt Fadeel,et al. Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[19] J. Au,et al. Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. , 2012, Advanced drug delivery reviews.
[20] R. Jain,et al. Towards Optimal Design of Cancer Nanomedicines: Multi-stage Nanoparticles for the Treatment of Solid Tumors , 2015, Annals of Biomedical Engineering.
[21] A. Logan,et al. Angiogenesis , 1993, The Lancet.
[22] Ahmed O Elzoghby,et al. Albumin-based nanoparticles as potential controlled release drug delivery systems. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[23] R. Kontermann,et al. Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells , 2007, Journal of drug targeting.
[24] Y. Maitani,et al. Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex. , 2012, International journal of pharmaceutics.
[25] Dai Fukumura,et al. Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model , 2012, Annals of Biomedical Engineering.
[26] D. Livingston,et al. Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit* , 1996, The Journal of Biological Chemistry.
[27] R K Jain,et al. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Masamune,et al. Signal transduction in pancreatic stellate cells , 2009, Journal of Gastroenterology.
[29] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[30] R. Jain,et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. , 1992, Cancer research.
[31] A. Tsirigos,et al. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production , 2012, Cell cycle.
[32] Rakesh K. Jain,et al. Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.
[33] C. Nicholson,et al. In vivo diffusion of lactoferrin in brain extracellular space is regulated by interactions with heparan sulfate , 2008, Proceedings of the National Academy of Sciences.
[34] Robert Langer,et al. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[35] R. Wadsworth,et al. Tissue localization of nanoparticles is altered due to hypoxia resulting in poor efficacy of curcumin nanoparticles in pulmonary hypertension. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[36] V. Marek,et al. Effect of Hyaluronidase on Albumin Diffusion in Lung Interstitium , 1999, Lung.
[37] Jinming Gao,et al. Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. , 2011, Angewandte Chemie.
[38] Benjamin J Vakoc,et al. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging , 2009, Nature Medicine.
[39] You Han Bae,et al. pH-responsive sulfonamide/PEI system for tumor specific gene delivery: an in vitro study. , 2006, Biomacromolecules.
[40] M. Mazzone,et al. Altering the intratumoral localization of macrophages to inhibit cancer progression , 2014, Oncoimmunology.
[41] Mauro Ferrari,et al. Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment. , 2014, Cancer research.
[42] Yuhua Wang,et al. Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation , 2014, ACS nano.
[43] J. Verweij,et al. Matrix metalloproteinase inhibitors: current developments and future perspectives. , 2001, The Oncologist.
[44] Oliver Lieleg,et al. Selective filtering of particles by the extracellular matrix: an electrostatic bandpass. , 2009, Biophysical journal.
[45] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[46] Mikala Egeblad,et al. Dynamic interplay between the collagen scaffold and tumor evolution. , 2010, Current opinion in cell biology.
[47] P. Chu,et al. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. , 2011, Biomaterials.
[48] T. Graf,et al. PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells , 2008, Proceedings of the National Academy of Sciences.
[49] M. Uesaka,et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.
[50] Joo H. Kang,et al. Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix. , 2012, Nano letters.
[51] S. Inoue. Ultrastructure of basement membranes. , 1989, International review of cytology.
[52] K. Chennazhi,et al. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. , 2011, Journal of colloid and interface science.
[53] Kostas Kostarelos,et al. Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[54] Shyh-Dar Li,et al. Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis. , 2013, Cancer research.
[55] Huan Meng,et al. Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice. , 2013, ACS nano.
[56] R. Zhuo,et al. Synthesis of Thermo-Sensitive Micellar Aggregates Self-Assembled from Biotinylated PNAS-b-PNIPAAm-b-PCL Triblock Copolymers for Tumor Targeting , 2009 .
[57] M. Loeffler,et al. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.
[58] Y. Byun,et al. Metalloprotease-specific poly(ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis. , 2003, Drugs under experimental and clinical research.
[59] Y. Byun,et al. MMPs-specific PEGylated peptide-DOX conjugate micelles that can contain free doxorubicin. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[60] Z. Werb,et al. Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.
[61] Brendan P. Flynn,et al. Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[62] Jianhua Huang,et al. A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation , 2008, Nature.
[63] R. Müller,et al. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns , 2005, Journal of drug targeting.
[64] M. Wientjes,et al. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. , 2001, The Journal of pharmacology and experimental therapeutics.
[65] Triantafyllos Stylianopoulos,et al. The role of mechanical forces in tumor growth and therapy. , 2014, Annual review of biomedical engineering.
[66] R. Gillies,et al. pH and drug resistance in tumors. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[67] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. , 1995, International archives of allergy and immunology.
[68] D. S. Lee,et al. Environmental pH-sensitive polymeric micelles for cancer diagnosis and targeted therapy. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[69] Zhishen Ge,et al. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. , 2013, Chemical Society reviews.
[70] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[71] Saroja Ramanujan,et al. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. , 2002, Biophysical journal.
[72] G. Ruben,et al. Basement membrane structure in situ: evidence for lateral associations in the type IV collagen network , 1987, The Journal of cell biology.
[73] Edrun A. Schnell,et al. Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts. , 2010, Anticancer research.
[74] G. Bernhardt,et al. Hyaluronidase enhances the activity of Adriamycin in breast cancer models in vitro and in vivo , 2005, Journal of Cancer Research and Clinical Oncology.
[75] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[76] A. Ciobica,et al. Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[77] D. McDonald,et al. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. , 2003, The American journal of pathology.
[78] E. Puré,et al. Nanoparticles Functionalized with Collagenase Exhibit Improved Tumor Accumulation in a Murine Xenograft Model , 2014, Particle & particle systems characterization : measurement and description of particle properties and behavior in powders and other disperse systems.
[79] G. Hostetter,et al. Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. , 2011, Cancer discovery.
[80] Leaf Huang,et al. Exploring the tumor microenvironment with nanoparticles. , 2015, Cancer treatment and research.
[81] R. Pirola,et al. Pancreatic stellate cells: a starring role in normal and diseased pancreas , 2012, Front. Physio..
[82] Ru Cheng,et al. pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances. , 2014, Nanomedicine.
[83] Jinming Gao,et al. Multicolored pH-tunable and activatable fluorescence nanoplatform responsive to physiologic pH stimuli. , 2012, Journal of the American Chemical Society.
[84] Amy Brock,et al. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. , 2014, Advanced drug delivery reviews.
[85] Yanling Luo,et al. Synthesis and micellization of thermosensitive PNIPAAm-b-PLA amphiphilic block copolymers based on a bifunctional initiator , 2011 .
[86] G. Palade,et al. Neovasculature induced by vascular endothelial growth factor is fenestrated. , 1997, Cancer research.
[87] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[88] E. Amento,et al. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. , 1990, The Journal of biological chemistry.
[89] D. Hanahan,et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. , 1998, The Journal of clinical investigation.
[90] Emanuel Fleige,et al. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. , 2012, Advanced drug delivery reviews.
[91] Bo Ri Seo,et al. In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. , 2014, Advanced drug delivery reviews.
[92] Triantafyllos Stylianopoulos,et al. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.
[93] B. Strehlow,et al. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof. , 2014, Colloids and surfaces. B, Biointerfaces.
[94] G. V. van Rhoon,et al. Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[95] R. Gemeinhart,et al. Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. , 2005, Bioconjugate chemistry.
[96] Parag Aggarwal,et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.
[97] C. de Lange Davies,et al. Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts , 2005, British Journal of Cancer.
[98] V. Muzykantov,et al. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities , 2012, Science.
[99] 矢原 敏郎. Relationship between microvessel density and thermographic hot areas in breast cancer , 2003 .
[100] J. Au,et al. Tumor Priming Enhances Delivery and Efficacy of Nanomedicines , 2007, Journal of Pharmacology and Experimental Therapeutics.
[101] R. Jain,et al. TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma , 2012, Proceedings of the National Academy of Sciences.
[102] Michael M. Schmidt,et al. A modeling analysis of the effects of molecular size and binding affinity on tumor targeting , 2009, Molecular Cancer Therapeutics.
[103] Triantafyllos Stylianopoulos,et al. Diffusion anisotropy in collagen gels and tumors: the effect of fiber network orientation. , 2010, Biophysical journal.
[104] Wilson Mok,et al. Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivo. , 2009, Biophysical journal.
[105] Y. Ouchi,et al. Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor‐β receptor inhibitor on extravasation of nanoparticles from neovasculature , 2009, Cancer science.
[106] J. Pouysségur,et al. Hypoxia and cancer , 2007, Journal of Molecular Medicine.
[107] Brian Seed,et al. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation , 2003, Nature Medicine.
[108] Ameya R. Kirtane,et al. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities. , 2013, Advanced drug delivery reviews.
[109] R. Jain,et al. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors , 2011, Proceedings of the National Academy of Sciences.
[110] S. Strychor,et al. Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts , 2007, Clinical Cancer Research.
[111] R. Swann,et al. Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy , 2013, Clinical Cancer Research.
[112] Tuo Wei,et al. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. , 2012, ACS nano.
[113] Ou Chen,et al. Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. , 2011, Angewandte Chemie.
[114] B. Bauvois,et al. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. , 2012, Biochimica et biophysica acta.
[115] M. Dewhirst,et al. Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. , 2012, Cancer research.
[116] Christine Allen,et al. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. , 2010, Molecular pharmaceutics.
[117] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[118] C. de Lange Davies,et al. Hyaluronidase reduces the interstitial fluid pressure in solid tumours in a non-linear concentration-dependent manner. , 1998, Cancer letters.
[119] R K Jain,et al. Vascular permeability in a human tumour xenograft: molecular charge dependence , 2000, British Journal of Cancer.
[120] J. Bouchal,et al. The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance , 2014, Cancer Cell International.
[121] S. Denmeade,et al. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin , 2009, Molecular Cancer Therapeutics.
[122] Dai Fukumura,et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue , 2011, Proceedings of the National Academy of Sciences.
[123] R. Jain,et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.
[124] C. Scudamore,et al. Triggered doxorubicin release in solid tumors from thermosensitive liposome‐peptide hybrids: Critical parameters and therapeutic efficacy , 2015, International journal of cancer.
[125] H. Dvorak,et al. Vascular permeability, vascular hyperpermeability and angiogenesis , 2008, Angiogenesis.
[126] G. Peters,et al. Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma , 1996, Molecular and cellular biology.
[127] H. Kuh,et al. Improving drug delivery to solid tumors: priming the tumor microenvironment. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[128] Ming-Zher Poh,et al. Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. , 2010, Biophysical journal.
[129] T. Löffler,et al. A temperature-sensitive brain tumor suppressor mutation of Drosophila melanogaster: Developmental studies and molecular localization of the gene , 1993, Mechanisms of Development.
[130] Rakesh K. Jain,et al. Pathology: Cancer cells compress intratumour vessels , 2004, Nature.
[131] R. Jain,et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.
[132] F. Zunino,et al. The potential of heparanase as a therapeutic target in cancer. , 2014, Biochemical pharmacology.
[133] R. Baron,et al. Engineered nanomedicine for myeloma and bone microenvironment targeting , 2014, Proceedings of the National Academy of Sciences.
[134] Vincent M. Rotello,et al. Tuning Payload Delivery in Tumour Cylindroids using Gold Nanoparticles , 2010, Nature nanotechnology.
[135] Paula T Hammond,et al. Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia. , 2011, ACS nano.
[136] V. Conticello,et al. Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences. , 2002, Advanced drug delivery reviews.
[137] H. Dvorak. Tumors: Wounds That Do Not Heal—Redux , 2015, Cancer Immunology Research.
[138] R. Drezek,et al. In vivo immune cell distribution of gold nanoparticles in naïve and tumor bearing mice. , 2014, Small.
[139] Kristian Pietras,et al. High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.
[140] Yuan Zhang,et al. Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[141] Dai Fukumura,et al. Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in tumor vascular networks , 2010, Nature Methods.
[142] M. Kano. Nanotechnology and tumor microcirculation. , 2014, Advanced drug delivery reviews.
[143] Derek S. Chan,et al. The Pancreas Cancer Microenvironment , 2012, Clinical Cancer Research.
[144] Triantafyllos Stylianopoulos,et al. Combining two strategies to improve perfusion and drug delivery in solid tumors , 2013, Proceedings of the National Academy of Sciences.
[145] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[146] Derek S. Chan,et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer , 2012, Gut.
[147] Charles M Perou,et al. Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models , 2014, Clinical Cancer Research.
[148] Huile Gao,et al. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma. , 2015, Nanoscale.
[149] M. Kano,et al. Pericyte-coverage of human tumor vasculature and nanoparticle permeability. , 2012, Biological & pharmaceutical bulletin.
[150] N. Block,et al. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. , 1997, Cancer research.
[151] R. B. Campbell,et al. Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors , 2004, Nature Medicine.
[152] Wilson Mok,et al. Mathematical Modeling of Herpes Simplex Virus Distribution in Solid Tumors: Implications for Cancer Gene Therapy , 2009, Clinical Cancer Research.
[153] S. Andò,et al. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production , 2012, Cell cycle.
[154] E. Rofstad,et al. Tumor Interstitial Fluid Pressure—A Link between Tumor Hypoxia, Microvascular Density, and Lymph Node Metastasis , 2014, Neoplasia.
[155] R. Jain,et al. Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks in vivo , 2010 .
[156] M. Wientjes,et al. Determinants of paclitaxel penetration and accumulation in human solid tumor. , 1999, The Journal of pharmacology and experimental therapeutics.
[157] R K Jain,et al. Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. , 1989, Cancer research.
[158] L. Gerweck,et al. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.
[159] K. Chennazhi,et al. Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery. , 2011, International journal of biological macromolecules.
[160] U. Landegren,et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. , 2003, Genes & development.
[161] C. Betsholtz,et al. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.
[162] Ick Chan Kwon,et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. , 2014, Biomaterials.
[163] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[164] K. Greish,et al. Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect , 2014, International journal of nanomedicine.
[165] Umar Mahmood,et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.
[166] Brandon S. Brown,et al. Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix , 2014, ACS nano.
[167] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[168] S. Pun,et al. Increased nanoparticle penetration in collagenase-treated multicellular spheroids , 2007, International journal of nanomedicine.
[169] Z. Werb,et al. The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.